PKF275-055, an analog of vildagliptin, is a novel, selective, orally bioavailable, and long-acting DPP-4 inhibitor that has shown promising benefits in the prevention, protection, and treatment of diabetic neuropathy
Fast turnaround times most peptide orders ship within 24-48 hours of prescription receipt
Industry Experts were contacted for insights on the evolving treatment landscape, patient reliance on conventional therapies, patient therapy switching acceptability, and drug uptake along with challenges related to accessibility
Heres what you can take or add to your diet to help fight it
Studies in rats provide further evidence that the SSBW produced by obesity pharmacotherapy is the outcome of active dysregulation of BW